The Food and Drug Administration has confirmed that multinational Johnson & Johnson has begun the process of registering its single-dose vaccine in Thailand. However, Surachoke Tangwiwat from the FDA adds that some required paperwork is still missing and will need to be filed within 30 days. Meanwhile, the FDA has begun checking the documentation that has been submitted.
Surachoke adds that, while the Chinese Sinovac jab has still not been registered for use in China, it may be given approval in the Kingdom, subject to the FDA concluding it is effective and safe.
Meanwhile, the AstraZeneca vaccine, developed in conjunction with the UK’s Oxford University, was approved last week. However, Thailand’s plans to import its first doses this month has been affected by an EU ruling limiting exports of the jab, following a supply row between the bloc and the manufacturer.
The EU is fighting…
